Cell Therapy Market - Top Companies and Manufacturers

  • Report ID: 6155
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Companies Dominating the Cell Therapy Landscape

    The market for cell therapy consists of many key players who are launching various strategic initiatives to expand their market position in the industry.

    • Nkarta, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Novartis AG
    • Gilead Sciences, Inc.
    • Bristol-Myers Squibb Company
    • Johnson & Johnson Services, Inc
    • JCR Pharmaceuticals Co., Ltd.
    • JW Therapeutics
    • Atara Biotherapeutics
    • Anterogen Co., Ltd.
    • MEDIPOST Co., Ltd.
    • S. BIOMEDICS
    • Aurion Biotech
    • Cytiva
    • Pluri Biotech Ltd.

Browse Key Market Insights with Data Illustration:

In the News

  • Cytiva announced the introduction of Sefia next-generation manufacturing platform to assist pharmaceutical companies and bigger healthcare providers in speeding up the manufacture of less expensive chimeric antigen receptor T (CAR T) cell therapies and offers more automation than earlier cell therapy systems which reduces the possibility of human mistake during treatment manufacture.
  • Pluri Biotech Ltd. has extended its operations for cell-based products to assist other businesses with their development plans for lending its expertise, resources, and infrastructure to other companies so they can create stem cells, induced pluripotent stem cells, exosomes, and immunotherapeutics.

Author Credits:  Radhika Pawar


  • Report ID: 6155
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cell therapy is estimated at USD 6.95 billion.

The cell therapy market size was valued at USD 5.93 billion in 2024 and is likely to cross USD 73.77 billion by 2037, registering more than 21.4% CAGR during the forecast period i.e., between 2025-2037. It is believed that the rising incidence of cancer across the globe will boost the market growth.

Asia Pacific industry is predicted to account for largest revenue share of 59% by 2037, due to growing advancements in medical research in the region.

The major players in the market are Novartis AG, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc, JCR Pharmaceuticals Co., Ltd., JW Therapeutics, Atara Biotherapeutics, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample